 |
Our Vision -- transforming cervical cancer screening worldwide
Preciva is developing electronic screening tools to give every woman an equal chance to live free of cervical cancer. We are an impact-driven company that will measure success not just in terms of profits but also in terms of improved access to health care and benefits to women's health and well-being.
Developing innovative healthcare products with a socially responsible corporate ethos, Preciva seeks to realize two goals:
providing access for every woman to accurate cervical screening and diagnosis;
shifting high-income health care systems to strategies which favor
non-interventional
In low income countries, financial, geographical, and cultural barriers limit access to cervical cancer screening which results in high rates of easily preventable deaths. In high income countries, intervention at the early precursor stage is common, an approach which has physical, psychological, and financial consequences for patients, communities, and health-care systems. Preciva addresses both of these challenges through the development of new screening and diagnostic tests which are more accessible, more accurate, and more supportive of personal health autonomy.
Preciva’s premise is that sophisticated technology for examining cervical tissue can produce the highest quality results in worldwide settings, independently of existing infrastructure. Preciva products are designed for thoroughness of sampling, accuracy of analysis, simplicity of use, and ease of manufacture. Preciva intends to transform the diagnosis and treatment process so that women are able to make informed decisions based on non-subjective information that they can monitor over time. We seek partnerships with individuals and organizations that share the goals of advancing personal health autonomy and eliminating different standards in health care for rich and poor communities.
|
